Nath Bio-Genes (India) Ltd.

NSE: NATHBIOGEN | BSE: 537291

Mid-range Performer

Download real time

167.42 -0.54 (-0.32%)

36.66% Fall from 52W High

24,353 NSE+BSE Volume

NSE 22 Apr, 2025 3:31 PM (IST)

318.2

Market Cap

Below industry Median

1.2

Beta 1Year

High Volatility

Board Meeting

The next board meeting for Nath Bio-Genes (India) Ltd. is on 29 Apr 2025 for the purpose of Audited Results & Final Dividend See details

Nath Bio-Genes (India) Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Nath Bio-Genes (India) Ltd. from all sources in a single place.

Load latest

Nath Bio-Genes (India) Ltd.

08 May 2024

167.42

-0.32%

Investor Presentation

Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on Audited Financial Results as on 31st March 2024.

Nath Bio-Genes (India) Ltd.

08 May 2024

167.42

-0.32%

Board Meeting

Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Outcome for Outcome Of Board Meeting Held …

BSE India

Outcome of Board meeting held on 08th May 2024 for approval of 1. Audited Financial Results as on 31st March 2024. 2. Recommendation of Dividend by Board of Directors 3. Date of Annual General Meeting of the Company for financial year 2023-24

Nath Bio-Genes (India) Ltd.

08 May 2024

167.42

-0.32%

Result

Nath Bio-Genes (India) Ltd - 537291 - Audited Financial Results As At 31St March 2024

BSE India

Outcome of Board Meeting of the Company held on 08th May 2024.

Nath Bio-Genes (India) Ltd.

08 May 2024

167.42

-0.32%

Annual Report

Annual report for Nath Bio-Genes (India) Ltd. for FY-2024

None

Nath Bio-Genes (India) Ltd.

06 May 2024

167.42

-0.32%

Company Update

Nath Bio-Genes (India) Ltd - 537291 - Intimation Of Earing Conference Call

BSE India

Intimation of Earning Conference Call to be held on 09th May at 04:00 PM

Nath Bio-Genes (India) Ltd.

30 Apr 2024

167.42

-0.32%

Board Meeting

Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Intimation for 1. Approval Of Audited Financial …

BSE India

Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2024 ,inter alia, to consider and approve Audited Financial Results for the year ended 31st March 2024.

Nath Bio-Genes (India) Ltd.

24 Apr 2024

167.42

-0.32%

Company Update

Nath Bio-Genes (India) Ltd - 537291 - Compliance Certificate

BSE India

Compliance Certificate under Regulation 40 (10) of SEBI (LODR) Regulations, 2015, for the period ended 31st March 2024

Nath Bio-Genes (India) Ltd.

15 Apr 2024

167.42

-0.32%

Company Update

Nath Bio-Genes (India) Ltd - 537291 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018, for the period ended 31st March 2024

Nath Bio-Genes (India) Ltd.

12 Apr 2024

167.42

-0.32%

Company Update

Nath Bio-Genes (India) Ltd - 537291 - Compliance Certificate

BSE India

Compliance Certificate under Reg 7(3) of SEBI, (LODR) Regulations for the period ended 31st March 2024.

Nath Bio-Genes (India) Ltd.

27 Mar 2024

167.42

-0.32%

Company Update

Nath Bio-Genes (India) Ltd - 537291 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015.

BSE India

Inter-se transfer of shares among the Promoters

Is Nath Bio-Genes (India) Ltd. worth buying?

121 Votes:

Buy 83.47%

Sell 11.57%

Hold 4.96%